SPINEART announces over 3,000 patients treated with SCARLET® AC-T in the USA

SCARLET® AC-T is the first stand-alone cervical device offered by Spineart. The titanium cage, secured with bone screws, is inserted flush to vertebral bodies thus reducing potential risks associated with dysphagia and adjacent-level ossification.  With lordotic and anatomic profiles, 2 footprints, and multiple cage heights, SCARLET® AC-T allows surgeons to address variable patient anatomy while providing optimal fit between endplates.  

As with all of Spineart’s ever-expanding spine portfolio, the SCARLET® AC-T system is comprised of sterile-packed implants and one compact instrument set.

More information on SCARLET® AC-T on : /products/scarlet-ac-t/

Related

Related items
Date - Category Illustration Title Excerpt
  • Corporate
26 September 2025 Plan-Les-Ouates & Zurich (CH) – Antwerp (BE) Spineart (www.spineart.com), a global medtech innovator in advanced spine surgery solutions, today announces a CHF 25 million capital increase backed...
  • Produits
Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States. Following 510(k) clearance in May 2024, SCARLET® AC-Ti has been extensively evaluated by...
  • BAGUERA® C
Spineart today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its innovative cervical disc prosthesis, met the...